• Most Popular
  • Most Shared

US FDA approves NeurogesX Qutenza pain patch

Mon Nov 16, 2009 5:14pm EST

Stocks

   

WASHINGTON, Nov 16 (Reuters) - The U.S. Food and Drug Administration has approved NeurogesX Inc's (NGSX.O) Qutenza pain patch for shingles, the company said on Monday.

Stocks  |  Healthcare

The non-narcotic patch is put directly to the site of pain and can help reduce the discomfort, often severe, for up to three months, the company said in a statement.

In June, NeurogesX Inc (NGSX.O) announced a distribution agreement with Japan's Astellas Pharma Inc (4503.T) to sell Qutenza, in the European Economic Area, the Middle East and Africa. (Reporting by Maggie Fox; editing by Andre Grenon)

Stocks
Healthcare


More from Reuters

Photo

U.S. health bill passes crucial Senate test

WASHINGTON (Reuters) - A broad healthcare overhaul passed its first crucial test in the U.S. Senate on Monday, with 60 Democrats voting to put President Barack Obama's top legislative priority on a path to passage by Christmas. | Video

» More Top News
A woman shops at a Sam's Club store, a division of Wal-Mart Stores, in Bentonville, Arkansas June 4, 2009. REUTERS/Jessica Rinaldi

The food-stamp economy

On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America?  Full Article 

U.S.
Two men shake hands in a file photo. REUTERS/File

Let's make a deal

The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis.  Full Article 

Global Deals Review